Effect of Salbutamol on Walking Capacity in Ambulatory ALS Patients

Clinical trial NCT05860244 · UNKNOWN

Trial details

NCT number: NCT05860244
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Walking Capacity Amyotrophic Lateral Sclerosis

Start date: 2024-09-01
Primary completion: 2025-07-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.